506.16MMarket Cap-339P/E (TTM)
16.480High15.950Low328.75KVolume16.200Open15.845Pre Close5.33MTurnover1.06%Turnover RatioLossP/E (Static)31.05MShares23.36052wk High0.14P/B506.16MFloat Cap12.51052wk Low--Dividend TTM31.05MShs Float23.360Historical High--Div YieldTTM3.35%Amplitude12.510Historical Low16.226Avg Price1Lot Size
Grail Stock Forum
GRAIL Advances the Galleri® Registrational Clinical Trial Program
GRAIL (NASDAQ: GRAL) has announced significant progress in its clinical trials for the Galleri® multi-cancer early detection (MCED) test. The company has completed enrollment of over 35,000 participants in the PATHFINDER 2 study across North America and finished the final study visits for the NHS-Galleri trial with more than 140,000 participants in England. Results from the first 25,000 PATHFINDER 2 participan...
No comment yet